Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.15
+0.22 (3.71%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pulmonx Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 243 | 488 | 315 | 1,181 | 2,462 | - | |
| Market Cap Growth | -17.37% | 54.88% | -73.31% | -52.01% | - | - | |
| Enterprise Value | 191 | 391 | 184 | 1,006 | 2,687 | - | |
| Last Close Price | 6.15 | 12.75 | 8.43 | 32.07 | 69.02 | - | |
| PS Ratio | 3.01 | 7.11 | 5.88 | 24.40 | 75.21 | - | |
| PB Ratio | 2.59 | 4.13 | 2.05 | 6.11 | 10.89 | - | |
| P/TBV Ratio | 3.54 | 4.21 | 2.08 | 6.20 | 11.02 | - | |
| EV/Sales Ratio | 2.41 | 5.69 | 3.42 | 20.77 | 82.09 | - | |
| Debt / Equity Ratio | 0.59 | 0.35 | 0.16 | 0.14 | 0.12 | 1.21 | |
| Asset Turnover | 0.45 | 0.37 | 0.25 | 0.19 | 0.21 | 0.95 | |
| Inventory Turnover | 1.24 | 1.14 | 0.89 | 0.95 | 1.41 | 2.28 | |
| Quick Ratio | 6.56 | 5.62 | 8.13 | 10.65 | 18.85 | 2.42 | |
| Current Ratio | 7.70 | 6.50 | 9.14 | 11.85 | 19.96 | 2.90 | |
| Return on Equity (ROE) | -51.99% | -44.68% | -33.94% | -23.21% | -26.41% | - | |
| Return on Assets (ROA) | -20.04% | -20.84% | -17.09% | -11.85% | -12.74% | -32.53% | |
| Return on Capital (ROIC) | -22.23% | -22.89% | -18.41% | -12.50% | -13.79% | -47.86% | |
| Earnings Yield | -23.52% | -12.46% | -18.68% | -4.12% | -1.31% | - | |
| FCF Yield | -14.33% | -7.87% | -14.71% | -3.81% | -1.28% | - | |
| Buyback Yield / Dilution | -2.88% | -2.37% | -2.68% | -254.74% | -473.44% | -6.05% | |
| Total Shareholder Return | -2.88% | -2.37% | -2.68% | -254.74% | -473.44% | -6.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.